IRADIMED CORPORATION Accounts Receivable
IRADIMED CORPORATION (IRMD) had Accounts Receivable of $13.19 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-07-31
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $13.19M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $13.41M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $13.67M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $13.86M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $13.19M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $13.41M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $13.67M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $13.86M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $10.92M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $12.71M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $10.56M 10-K · filed 2026-03-06 | $10.56M 10-K · filed 2025-03-06 |
| 2024-09-30 | $10.36M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $11.95M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $13.03M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $12.22M 10-K/A · filed 2025-09-03 | |
| 2023-09-30 | $12.78M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $11.08M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $11.53M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $13.27M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $10.65M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $8.38M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $6.51M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $5.14M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $4.25M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $3.88M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $4.56M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $4.57M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $4.25M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $4.51M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $5.85M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $7.29M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $6.92M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $5.88M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $5.33M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $4.21M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $5.22M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $3.98M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $3.28M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $3.78M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $3.51M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $3.79M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $3.74M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $3.78M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $4.49M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $5.79M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $4.64M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $3.86M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $3.43M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $4.26M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $3.52M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.96M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $1.17M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $2.28M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $1.98M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |